Evrysdi treatment safe, effective in adults with SMA: Real-world study
Treatment with Evrysdi (risdiplam) is generally safe and effective at improving or stabilizing motor and lung function in adults with spinal muscular atrophy (SMA) for up to two years, according to a real-world study in Belgium. Results also suggested easing of difficulty swallowing and fatigue, as well as…